Alex Kildani
Senior Vice President of Investor Relations and Corporate Communications
Replay available
ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) Q4 2025 earnings conference call, held 2026-02-25. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Catherine Owen Adams
Chief Executive Officer
Tom Garner
Chief Commercial Officer
Mark Schneier
Chief Financial Officer
Tess Romero
Analyst, JP Morgan
Rita Baral
Analyst, TD Cowen
Mark Goodman
Analyst, Lyric
Rudy Lee
Analyst, Wolfe Research
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Acadia Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.476 Thank you for standing by. My name is JL, and I will be your conference operator today. 00:00:04.476 -- 00:00:08.120 At this time, I would like to welcome everyone to the Acadia Pharmaceuticals Incorporated 00:00:08.120 -- 00:00:12.585 fourth quarter earnings call. All lines have been placed on mute to prevent any background 00:00:12.585 -- 00:00:17.250 noise. After the speaker's remarks, there will be a question and answer session. 00:00:17.250 -- 00:00:20.233 If you would like to ask a question during this time, simply press star, followed by 00:00:20.233 -- 00:00:24.417 the number one on your telephone keypad. If you would like to withdraw your question, 00:00:24.417 -- 00:00:29.410 simply press star one again. I would now like to turn the conference over to Alex. 00:00:29.410 -- 00:00:33.716 Kildani, Senior Vice President of Investor Relations and Corporate Communications. 00:00:33.716 -- 00:00:34.276 You may begin. 00:00:34.276 -- 00:00:36.276 Good 00:00:36.439 -- 00:00:40.665 afternoon, and thank you for joining us on today's call to discuss Acadia's fourth quarter 00:00:40.665 -- 00:00:45.732 and full year 2025 financial results. Joining me on the call today 00:00:45.732 -- 00:00:50.278 from Acadia are Catherine Owen Adams, our Chief Executive Officer, who will provide some 00:00:50.278 -- 00:00:54.884 opening remarks, followed by Tom Garner, our Chief Commercial Officer, who will discuss 00:00:54.884 -- 00:00:57.693 our commercial brands, Debut and New Placid. 00:00:57.693 -- 00:01:02.442 Also joining us today is Elizabeth Thompson, PhD, Executive Vice President, Head of Research 00:01:02.442 -- 00:01:06.930 and Development, who will provide an update on our pipeline programs, and Mark Schneier, 00:01:06.930 -- 00:01:10.637...